COVID-19 Virus Infection

• EMA withdrawal · 2025-09-01
  EMA Withdrawn: Jcovden (previously COVID-19 Vaccine Janssen) (adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)) — Janssen-Cilag International NV

  The EMA has withdrawn the European marketing authorization for Jcovden (COVID-19 vaccine Janssen), an Ad26.COV2-S vaccine, effective as of 2…

• EMA withdrawal · 2023-12-01
  EMA Withdrawn: COVID-19 Vaccine (inactivated, adjuvanted) Valneva (COVID-19 vaccine (inactivated, adjuvanted, adsorbed)) — Valneva Austria GmbH

  The EMA withdrew the COVID-19 vaccine (inactivated, adjuvanted, adsorbed) from Valneva Austria GmbH.

• CLINICAL_TRIALS withdrawal · 2021-11-24
  Clinical Trial Update: High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19 [Phase 4]

  Phase 4 trial investigating high-dose corticosteroids or tocilizumab for clinical worsening in COVID-19 has been withdrawn.